Clinical Trials Browser

OTHER × Pyruvic Acid × 90 days × Clear all

NCT06384222 2025-12-30

Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone

Phase 2 Recruiting

Prostatic Neoplasms